Do women taking hormone replacement therapy have a higher uptake of screening mammograms?
All British women in the 50-64 age group are now offered three yearly screening mammograms. A study was undertaken to compare the uptake of three yearly screening mammograms for women taking hormone replacement therapy with those not on treatment. Out of a list size of 15,000, there were 1309 women aged 50 to 64. Of these 265/286 (92.7%) of women taking hormone replacement therapy, and 877/1023 (85.7%) not taking treatment, attended for mammograms. Overall 286/1309 (21.8%), and in the 50-54 subgroup 193/524 (36.8%), were taking hormone replacement therapy. This study supports the idea that there is a selection bias with women taking hormone replacement therapy significantly more likely to attend for screening mammograms.